Company · CIK 1412558
Evotec SE
| CIK | 1412558 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | 2M |
| Listed | EVO (Nasdaq), EVOTF (OTC) |
| First annual or quarterly report | 2008-06-30 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260143 | 2021-10-08 | 2021-11-05 | 7 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-11-05 | 424B4Final prospectus | 333-260143 | 0001193125-21-321692 |
| 2021-11-03 | EFFECTDeclared effective | 333-260143 | 9999999995-21-004175 |
| 2021-10-29 | F-1/AAmendment | 333-260143 | 0001193125-21-312901 |
| 2021-10-28 | F-1/AAmendment | 333-260143 | 0001193125-21-310388 |
| 2021-10-26 | F-1/AAmendment | 333-260143 | 0001193125-21-307743 |
| 2021-10-22 | F-1/AAmendment | 333-260143 | 0001193125-21-304665 |
| 2021-10-08 | F-1Registration filed | 333-260143 | 0001193125-21-295475 |
| 2021-07-09 | DRSDraft made public | 377-05179 | 0000950123-21-008609 |
| 2008-03-25 | EFFECTDeclared effective | 333-148604 | 9999999995-08-000881 |
| 2008-03-25 | EFFECTDeclared effective | 333-148488 | 9999999995-08-000880 |